Inactivated Tianjin strain, a novel genotype of Sendai virus, induces apoptosis in HeLa, NCI-H446 and Hep3B cells

Chen,Jun; Han,Han; Wang,Bin; Shi,Liying

doi:10.3892/ol.2016.4570

Inactivated Tianjin strain, a novel genotype of Sendai virus, induces apoptosis in HeLa, NCI-H446 and Hep3B cells

Authors:
- Jun Chen
- Han Han
- Bin Wang
- Liying Shi
View Affiliations

Affiliations: Department of Microbiology, Basic Medical College, Tianjin Medical University, Tianjin 300070, P.R. China, Department of Anesthesia and Critical Care Medicine, Translational Neuroscience Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China
Published online on: May 13, 2016 https://doi.org/10.3892/ol.2016.4570
Pages: 49-56
Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The Sendai virus strain Tianjin is a novel genotype of the Sendai virus. In previous studies, ultraviolet-inactivated Sendai virus strain Tianjin (UV-Tianjin) demonstrated antitumor effects on human breast cancer cells. The aim of the present study was to investigate the in vitro antitumor effects of UV‑Tianjin on the human cervical carcinoma HeLa, human small cell lung cancer NCI‑H446 and human hepatocellular carcinoma Hep 3B cell lines, and the possible underlying mechanisms of these antitumor effects. A 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay revealed that UV‑Tianjin treatment inhibited the proliferation of HeLa, NCI-H446 and Hep 3B cells in a dose‑ and time‑dependent manner. Hoechst and Annexin V-fluorescein isothiocyanate/propidium iodide double staining indicated that UV‑Tianjin induced dose‑dependent apoptosis in all three cell lines with the most significant effect observed in the HeLa cell line. In the HeLa cell line, UV‑Tianjin‑induced apoptosis was further confirmed by the disruption of the mitochondria membrane potential and the activation of caspases, as demonstrated by fluorescent cationic dye and colorimetric assays, respectively. In addition, western blot analysis revealed that UV‑Tianjin treatment resulted in significant upregulation of cytochrome c, apoptosis protease activating factor‑1, Fas, Fas ligand and Fas-associated protein with death domain, and activated caspase‑9, ‑8 and ‑3 in HeLa cells. Based on these results, it is hypothesized that UV‑Tianjin exhibits anticancer activity in HeLa, NCI‑H446 and Hep 3B cell lines via the induction of apoptosis. In conclusion, the results of the present study indicate that in the HeLa cell line, intrinsic and extrinsic apoptotic pathways may be involved in UV-Tianjin-induced apoptosis.

View Figures

View References

1	Prat J, Franceschi S, Denny L and Lazcano-Ponce E: Cancers of the female reproductive organs. World Cancer Report 2014, World Health Organization. Stewart BW and Wild CP: IARC Press. (Lyon). 678–680. 2014.
2	Forman D, Ferlay J, Stewart BW and Wild CP: The global and regional burden of cancer. World Cancer Report 2014, World Health Organization. Stewart BW and Wild CP: IARC Press. (Lyon). 28–30. 2014.
3	Theise ND, Chen CJ and Kew MC: Liver cancer. World Cancer Report 2014, World Health Organization. Stewart BW and Wild CP: IARC Press. (Lyon). 577–579. 2014.
4	Housman G, Byler S, Heerboth S, Lapinska K, Longacre M, Snyder N and Sarkar S: Drug resistance in cancer: An overview. Cancers (Basel). 6:1769–1792. 2014. View Article : Google Scholar : PubMed/NCBI
5	Yu H, Park J, Lee J, Choi K and Choi C: Constitutive expression of MAP kinase phosphatase-1 confers multi-drug resistance in human glioblastoma cells. Cancer Res Treat. 44:195–201. 2012. View Article : Google Scholar : PubMed/NCBI
6	Guan M, Romano G, Coroniti R and Henderson EE: Progress in oncolytic virotherapy for treatment of thyroid malignant neoplasm. J Exp Clin Cancer Res. 33:912014. View Article : Google Scholar : PubMed/NCBI
7	Woller N, Gürlevik E, Ureche CI, Schumacher A and Kühnel F: Oncolytic viruses as anticancer vaccines. Front Oncol. 4:1882014. View Article : Google Scholar : PubMed/NCBI
8	Chiocca EA and Rabkin SD: Oncolytic viruses and their application to cancer immunotherapy. Cancer Immunol Res. 2:295–300. 2014. View Article : Google Scholar : PubMed/NCBI
9	Shi JD, Li XM, Liu FY, Jin MJ, Zhang GJ, Liu M and Li Mei: Isolation and identification of a lethal viral pathogen from common cotton-eared marmosets. Virologica Sinica. 18:357–361. 2003.
10	Shi LY, Li M, Yuan LJ, Wang Q and Li XM: A new paramyxovirus, Tianjin strain, isolated from common cotton-eared marmoset: Genome characterization and structural protein sequences analysis. Arch Virol. 153:1715–1723. 2008. View Article : Google Scholar : PubMed/NCBI
11	Zhang Q and Xu X, Yuan Y, Gong X, Chen Z and Xu X: IPS-1 plays a dual function to directly induce apoptosis in murine melanoma cells by inactivated Sendai virus. Int J Cancer. 134:224–234. 2014. View Article : Google Scholar : PubMed/NCBI
12	Nomura M, Shimbo T, Miyamoto Y, Fukuzawa M and Kaneda Y: 13-Cis retinoic acid can enhance the antitumor activity of non-replicating Sendai virus particle against neuroblastoma. Cancer Sci. 104:238–244. 2013. View Article : Google Scholar : PubMed/NCBI
13	Morodomi Y, Yano T, Kinoh H, Harada Y, Saito S, Kyuragi R, Yoshida K, Onimaru M, Shoji F, Yoshida T, et al: BioKnife, a uPA activity-dependent oncolytic Sendai virus, eliminates pleural spread of malignant mesothelioma via simultaneous stimulation of uPA expression. Mol Ther. 20:769–777. 2012. View Article : Google Scholar : PubMed/NCBI
14	Shi L, Chen J, Zhong Q, Li M, Geng P, He J, Han Z, Sheng M and Tang H: Inactivated Sendai virus strain Tianjin, a novel genotype of Sendai virus, inhibits growth of murine colon carcinoma through inducing immune responses and apoptosis. J Transl Med. 11:2052013. View Article : Google Scholar : PubMed/NCBI
15	Yuan CX, Zhou ZW, Yang YX, He ZX, Zhang X, Wang D, Yang T, Wang NJ, Zhao RJ and Zhou SF: Inhibition of mitotic Aurora kinase A by alisertib induces apoptosis and autophagy of human gastric cancer AGS and NCI-N78 cells. Drug Des Devel Ther. 9:487–508. 2015.PubMed/NCBI
16	Fionda C, Abruzzese M, Zingoni A, Soriani A, Ricci B, Molfetta R, Paolini R, Santoni A and Cippitelli M: Nitric oxide donors increase PVR/CD155 DNAM-1 ligand expression in multiple myeloma cells: Role of DNA damage response activation. BMC Cancer. 15:172015. View Article : Google Scholar : PubMed/NCBI
17	Freeman-Keller M and Weber JS: Anti-programmed death receptor 1 immunotherapy in melanoma: Rationale, evidence and clinical potential. Ther Adv Med Oncol. 7:12–21. 2015. View Article : Google Scholar : PubMed/NCBI
18	Park KC, Heo JH, Jeon JY, Choi HJ, Jo AR, Kim SW, Kwon HJ, Hong SJ and Han KS: The novel histone deacetylase inhibitor, N-hydroxy-7-(2-naphthylthio) hepatonomide, exhibits potent antitumor activity due to cytochrome-c-release-mediated apoptosis in renal cell carcinoma cells. BMC Cancer. 15:192015. View Article : Google Scholar : PubMed/NCBI
19	Chen J, Lin C, Yong W, Ye Y and Huang Z: Calycosin and genistein induce apoptosis by inactivation of HOTAIR/p-Akt signaling pathway in human breast cancer MCF-7 Cells. Cell Physiol Biochem. 35:722–728. 2015.PubMed/NCBI
20	Nishizaki T, Kanno T, Tsuchiya A, Kaku Y, Shimizu T and Tanaka A: 1-[2-(2-Methoxyphenylamino)ethylamino]-3-(naphthalene-1-yloxy)propan-2-ol may be a promising anticancer drug. Molecules. 19:21462–21472. 2014. View Article : Google Scholar : PubMed/NCBI
21	Kaneda Y, Nakajima T, Nishikawa T, Yamamoto S, Ikegami H, Suzuki N, Nakamura H, Morishita R and Kotani H: Hemagglutinating virus of Japan (HVJ) envelope vector as a versatile gene delivery system. Mol Ther. 6:219–226. 2002. View Article : Google Scholar : PubMed/NCBI
22	Smiley ST, Reers M, Mottola-Hartshorn C, Lin M, Chen A, Smith TW, Steele GD and Chen LB: Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1. Proc Natl Acad Sci USA. 88:3671–3675. 1991. View Article : Google Scholar : PubMed/NCBI
23	Bredesen DE: Apoptosis: Overview and signal transduction pathways. J Neurotrauma. 17:801–810. 2000. View Article : Google Scholar : PubMed/NCBI
24	Gao H, Gong XC, Chen ZD, Xu XS, Zhang Q and Xu XM: Induction of apoptosis in hormone-resistant human prostate cancer PC3 cells by inactivated Sendai virus. Biomed Environ Sci. 27:506–514. 2014.PubMed/NCBI
25	Kerr JF, Wyllie AH and Currie AR: Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 26:239–257. 1972. View Article : Google Scholar : PubMed/NCBI
26	Schwartzman RA and Cidlowski JA: Apoptosis: The biochemistry and molecular biology of programmed cell death. Endocr Rev. 14:133–151. 1993. View Article : Google Scholar : PubMed/NCBI
27	Bergamaschi G, Rosti V, Danova M, Lucotti C and Cazzola M: Apoptosis: Biological and clinical aspects. Haematologica. 79:86–93. 1994.PubMed/NCBI
28	Frejlich E, Rudno-Rudzińska J, Janiszewski K, Salomon L, Kotulski K, Pelzer O, Grzebieniak Z, Tarnawa R and Kielan W: Caspases and their role in gastric cancer. Adv Clin Exp Med. 22:593–602. 2013.PubMed/NCBI
29	Ola MS, Nawaz M and Ahsan H: Role of Bcl-2 family proteins and caspases in the regulation of apoptosis. Mol Cell Biochem. 351:41–58. 2011. View Article : Google Scholar : PubMed/NCBI
30	Cohen GM: Caspases: The executioners of apoptosis. Biochem J. 326:1–16. 1997. View Article : Google Scholar : PubMed/NCBI
31	Pop C and Salvesen GS: Human caspases: Activation, specificity, and regulation. J Biol Chem. 284:21777–21781. 2009. View Article : Google Scholar : PubMed/NCBI
32	Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, et al: FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell. 85:817–827. 1996. View Article : Google Scholar : PubMed/NCBI
33	Srinivasula SM, Ahmad M, Fernandes-Alnemri T and Alnemri ES: Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Mol Cell. 1:949–957. 1998. View Article : Google Scholar : PubMed/NCBI
34	Hua Q, Wu D, Chen W, Yan Z, Yan C, He T, Liang Q and Shi Y: Molecular determinants of caspase-9 activation by the Apaf-1 apoptosome. Proc Natl Acad Sci USA. 46:16254–16261. 2014. View Article : Google Scholar
35	Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES and Wang X: Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 91:479–489. 1997. View Article : Google Scholar : PubMed/NCBI
36	Liu X, Kim CN, Yang J, Jemmerson R and Wang X: Induction of apoptotic programin cell-free extracts: Requirement for dATP and cytochrome c. Cell. 86:147–157. 1996. View Article : Google Scholar : PubMed/NCBI
37	Kim HE, Du F, Fang M and Wang X: Formation of apoptosome is initiated by cytochrome c induced dATP hydrolysis and subsequent nucleotide exchange on Apaf-1. Proc Natl Acad Sci USA. 102:17545–17550. 2005. View Article : Google Scholar : PubMed/NCBI
38	Bao Q, Lu W, Rabinowitz JD and Shi Y: Calcium blocks formation of apoptosome by preventing nucleotide exchange in Apaf-1. Mol Cell. 25:181–192. 2007. View Article : Google Scholar : PubMed/NCBI
39	Acehan D, Jiang X, Morgan DG, Heuser JE, Wang X and Akey CW: Three-dimensional structure of the apoptosome: Implications for assembly, procaspase-9 binding, and activation. Mol Cell. 9:423–432. 2002. View Article : Google Scholar : PubMed/NCBI
40	Nagata S and Golstein P: The Fas death factor. Science. 267:1449–1456. 1995. View Article : Google Scholar : PubMed/NCBI
41	Waring P and Müllbacher A: Cell death induced by the Fas/Fas ligand pathway and its role in pathology. Immunol Cell Biol. 77:312–317. 1999. View Article : Google Scholar : PubMed/NCBI
42	Kruidering M and Evan GI: Caspase-8 in apoptosis: The beginning of ‘the end’? IUBMB Life. 50:85–90. 2000. View Article : Google Scholar : PubMed/NCBI